All Articles Tagged "johnson & johnson"
In a case known as Hogans et al v. Johnson & Johnson et al out of St. Louis, a Missouri state jury concluded that Johnson & Johnson has to pay a whopping $72 million to the family of a one Jacqueline Fox. According to Reuters, Fox died of ovarian cancer, which was linked to her consistent use of the company’s old talc-based Baby Powder and Shower to Shower products for many years. More than 35 years actually. After being diagnosed with ovarian cancer three years ago, Fox passed away in October. She was 62 years old.
The family was awarded $10 million in actual damages and $62 million in punitive damages after jurors had decided Johnson & Johnson was liable for fraud, negligence and more, according to the family’s lawyer. According to Reuters, Johnson & Johnson is accused of failing to tell its customers that their line of talc-based products could cause cancer. The verdict in Hogans v. Johnson is the first in the United States to grant damages over claims made about cancer being caused by the beloved products. Nearly 1,000 cases have been filed in the state court of Missouri, alone, over such claims while 200 others have been filed in New Jersey.
Carol Goodrich, who is a spokeswoman for the company said, “We have no higher responsibility than the health and safety of consumers, and we are disappointed with the outcome of the trial. We sympathize with the plaintiff’s family but firmly believe the safety of cosmetic talc is supported by decades of scientific evidence.”
However, Jere Beasley, the lawyer for Fox’s family, said the company knew the risks of their products as far back as the ’80s and didn’t do much about it. Beasley says Johnson & Johnson are guilty of “lying to the public” and “lying to the regulatory agencies.”
The Centers for Disease Control made it official late last week: the flu outbreak has reached epidemic levels with 47 states reporting flu activity and 4.3 percent of outpatient visits attributed to flu symptoms. The threshold to reach epidemic level is 2.2. percent.
So this is bad news, right? For most people, yes. The Bureau of Labor Statistics reports that job absenteeism spikes during flu season, and this is the worst in a decade. According to sources speaking to The Wall Street Journal, businesses will lose billions because of this situation.
But not everyone is complaining. Ad Age reports that, unsurprisingly, companies in the cold and flu relief area are booming. Reckitt Benckiser, makers of Mucinex and Delsym, and Johnson & Johnson, which counts Children’s Motrin and Tylenol among its brands, are among the companies in this space that have seen an eight percent rise in sales.
And with efforts to avoid getting sick at a high, Lysol, Clorox, and other disinfectant brands are getting a 22 percent boost.
As we’ve previously reported, the best way to stave illness is to get vaccinated. But only 40 percent of Americans have done so for a variety of reasons, some good, some bad. The New Yorker cautions that even if you’re one of those people who refuse to get the vaccine, keep in mind that if you do get sick, you can pass it on to the most vulnerable in your family — children and the elderly. Or if you choose not to get it for yourself, perhaps you should press for members of these demographics to do so. As many as 45,000 Americans die every year from the flu. (!) Twenty people nationwide have died already, including six-year-old Tahlia Johnson, who’s funeral is pictured above. According to AP Images, it’s not certain whether she was vaccinated.
We did a little more digging to see if there’s anything more — anything at all — that companies can do to help employees. Unfortunately, the much-discussed hand washing and vaccination suggestions are really the only things we could find. Although this article suggests that companies can go an extra step toward bringing vaccinations to the office on a special day, making it available to anyone interested. With billions in losses at risk, it might be worth the trouble.
(AdAge.com) — Johnson & Johnson is reevaluating its global agency relationships on its portfolio of baby products, a move that could deal a blow to both its longtime lead creative shop for that brand, Interpublic Group of Cos.’ Lowe, along with digital shop Profero. The agency review, which will take six months to complete, follows other recent changes to the health-care giant’s agency roster. It comes as the company is under tremendous pressure to boost sagging sales and faces FDA scrutiny after repeated recalls for some of its over-the-counter medications.